ConductScience.org, home

Paper38536628

Evaluation of the histologic and immunohistochemical (CD34, glutamine synthetase) findings in idiopathic non-cirrhotic portal hypertension (INCPH).

Büyük M and 5 others. Hepatol Int, 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Evaluation of the histologic and immunohistochemical (CD34, glutamine synthetase) findings in idiopathic non-cirrhotic portal hypertension (INCPH). Papers, record 38536628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38536628

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of the histologic and immunohistochemical (CD34, glutamine synthetase) findings in idiopathic non-cirrhotic portal hypertension (INCPH).
PubMed
Journal
Hepatol Int
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.58, provisional
iCite
Revised in PubMed
2024-09-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Büyük MMelekhttps://orcid.org/0000-0003-3425-2137
2Berker NNeslihanhttps://orcid.org/0000-0002-0949-7944
3Bakkaloğlu DVDoğu Vurallıhttps://orcid.org/0000-0002-7671-0100
4Şenkal İVİbrahim Volkanhttps://orcid.org/0000-0002-4363-7197
5Önal ZZerrinhttps://orcid.org/0000-0002-7627-7423
6Güllüoğlu MMinehttps://orcid.org/0000-0002-3967-0779

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Glutamate-Ammonia LigaseMajor topic
Antigens, CD34Major topic
Hypertension, PortalMajor topic
LiverMajor topic
ImmunohistochemistryMajor topic
Humans
Male
Female
Middle Aged
Adult
Retrospective Studies
Aged
Portal Vein
Biopsy, Needle

Source PubMed

Download CSV of topics

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125230084Portal hypertension: pathophysiology, diagnosis and management.Intern Med J2015https://conductscience.org/library/papers/25230084PubMed
215818152Portal hypertension.Curr Opin Gastroenterol2005https://conductscience.org/library/papers/15818152PubMed
334007347Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data.Gastroenterology Res2021https://conductscience.org/library/papers/34007347PubMed
45833586Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis).Ann Surg1965https://conductscience.org/library/papers/5833586PubMed
512117894Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients.Gut2002https://conductscience.org/library/papers/12117894PubMed
621574171Idiopathic noncirrhotic portal hypertension.Hepatology2011https://conductscience.org/library/papers/21574171PubMed
721087805Obliterative portal venopathy: portal hypertension is not always present at diagnosis.J Hepatol2011https://conductscience.org/library/papers/21087805PubMed
811928079Idiopathic portal hypertension and its pathology.Semin Liver Dis2002https://conductscience.org/library/papers/11928079PubMed
912084024Non-cirrhotic portal fibrosis: current concepts and management.J Gastroenterol Hepatol2002https://conductscience.org/library/papers/12084024PubMed
108729037Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology.Histopathology1996https://conductscience.org/library/papers/8729037PubMed
1126264219Obliterative portal venopathy without portal hypertension: an underestimated condition.Liver Int2016https://conductscience.org/library/papers/26264219PubMed
1222707296Clinical analysis of 15 cases of liver nodular regenerative hyperplasia.Cell Biochem Biophys2012https://conductscience.org/library/papers/22707296PubMed
1315054815Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders.Am J Hematol2004https://conductscience.org/library/papers/15054815PubMed
142007779Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients.J Hepatol1991https://conductscience.org/library/papers/2007779PubMed
1526563701Idiopathic Noncirrhotic Portal Hypertension: An Appraisal.J Pathol Transl Med2016https://conductscience.org/library/papers/26563701PubMed
1629644430Pathology of idiopathic non-cirrhotic portal hypertension.Virchows Arch2018https://conductscience.org/library/papers/29644430PubMed
1731405536Idiopathic noncirrhotic portal hypertension.Semin Diagn Pathol2019https://conductscience.org/library/papers/31405536PubMed
1830129657Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition.Histopathology2019https://conductscience.org/library/papers/30129657PubMed
1923812828Obliterative portal venopathy: a clinical and histopathological review.Dig Dis Sci2013https://conductscience.org/library/papers/23812828PubMed
202189821Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules.Hepatology1990https://conductscience.org/library/papers/2189821PubMed

See all 33 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42741015Case Report: Primary myelofibrosis presenting with non-cirrhotic portal hypertension and initially misdiagnosed as cirrhosis.Front Med (Lausanne)2026https://conductscience.org/library/papers/42741015PubMed
42023120Clinicopathological features of non-cirrhotic portal fibrosis in primary biliary cholangitis: a 15-year experience at a tertiary referral center.Front Med (Lausanne)2026https://conductscience.org/library/papers/42023120PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
GLUL2752PubTator's text mininghttps://conductscience.org/library/genes/2752NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38536628

GET https://conductscience.org/api/papers/v1/38536628/references?page=2